M&A Deal Summary |
|
|---|---|
| Date | 2023-11-07 |
| Target | August |
| Sector | Life Science |
| Buyer(s) | Everest Clinical Research |
| Deal Type | Add-on Acquisition |
| Advisor(s) | Fairmount Partners (Financial) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2004 |
| Sector | Life Science |
Everest Clinical Research is a contract research organization (“CRO”) providing a comprehensive suite of mission-critical clinical research services to the worldwide pharmaceutical, biotechnology, and medical device industries across Phase I-IV trials. Everest Clinical Research was founded in 2004 and is based in Markham, Ontario.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: New York M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-12-01 |
Brightech
Somerset, New Jersey, United States Brightech is a CRO that specializes in complex, value-add biostatistics, programming, and clinical data management services. Brightech was formed in 2002 and is based in Somerset, New Jersey. |
Buy | - |